Israel Chemicals Ltd. announced the retirement of Mr. Avi Doitchman, Executive VP, CFO & Strategy, the company's HR & compensation Committee and the Board of Directors, approved the appointment and employment terms and conditions of Mr. Kobi Altman as Executive Vice President, CFO of the Company. Prior to his appointment as CFO of the Company, Mr. Altman served as Senior Vice President and CFO, Global Generics Medicine of Teva Pharmaceuticals Industries Ltd. and has formerly held several leading finance positions in Teva as well as in other large multinational companies. Mr. Altman will assume his duties as CFO on April 1, 2015, on which date Mr. Avi Doitchman will cease to serve as the Company's CFO.

Mr. Doitchman will continue to work with the Company as an external advisor.